---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-087115"
form_type: "8-K/A"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T04:00:56.074616+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Estrella Immunopharma changes fiscal year to June 30, effective Sept 29, 2023

## Summary
- Fiscal year end changed from December 31 to June 30, effective upon close of business combination.
- Change aligns fiscal year with Estrella Biopharma, the accounting acquirer in the combination.
- First fiscal year under new end will be the period ending June 30, 2024.

## SEC filing metadata
- accession: 0001213900-23-087115
- form_type: 8-K/A
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000121390023087115/0001213900-23-087115-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000121390023087115/ea188438-8ka1_estrella.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-087115
- JSON: https://secwatch.observer/filing/0001213900-23-087115.json
- Plain text: https://secwatch.observer/filing/0001213900-23-087115.txt

## Key facts
- Governance Changes
  Estrella Immunopharma, Inc.: Fiscal year end changed from December 31 to June 30 effective as of the closing date of the Business Combination (effective 2023-09-29).
  - Change: fiscal year change
  - Effective: 2023-09-29
  source text: Effective as of the closing date of the Business Combination on September 29, 2023, the Company’s fiscal year end changed from December 31 to June 30.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1844417/000121390023087115/0001213900-23-087115-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.